LIANRUI LI: Open Payments
NPI 1912283235 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46 in 2 payments from 2 companies in 2025. Trend: 2023 $1,407 · 2024 $236 · 2025 $46
Food & beverage: $46
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
Products named: NUCALA, UPTRAVI.
Industry payments across MD — which companies pay providers there.
